ChatGPT for PMHNPs: 26 Prompts That Cut Documentation & Ace the ANCC Exam

Jordan Ellis, MSN, PMHNP-BC runs a solo outpatient psychiatric practice in North Carolina — 18 patients a day, 18 psychiatric SOAP notes, prior authorizations for non-formulary antipsychotics, PDMP checks before every controlled substance prescription, and ANCC CE hours to track before her 5-year recertification window closes. Before ChatGPT, a single psychiatric SOAP note took 20 minutes of post-visit documentation; now it takes 4 minutes — a 16-minute saving multiplied by 18 patients adds up to nearly 5 hours back every single clinic day. The 26 prompts below are organized into five sections covering every documentation, compliance, exam prep, administrative, and career task a working PMHNP-BC faces, and every prompt is ready to copy, paste, and customize with real patient data.

Fully Worked Example 1 — Psychiatric SOAP Note

MDD + GAD Follow-Up · Time savings: 20 min → 4 min (80% reduction)

The Prompt:

You are a PMHNP-BC documenting a psychiatric SOAP note for a 34-year-old female follow-up for MDD (F32.1) and GAD (F41.1). PHQ-9: 12 (down from 17 at last visit). GAD-7: 9 (down from 14). Current medications: sertraline 100mg daily (tolerating well, no GI side effects), buspirone 10mg BID (added 3 weeks ago, tolerating well). Patient reports sleeping 6–7 hrs/night (improved from 4–5 hrs). Denies SI/HI. MSE: well-groomed, cooperative, normal rate speech, mood "a little better," affect mildly constricted but reactive, thought process linear and goal-directed, no psychotic symptoms, insight good, judgment intact. Plan: continue current medications, add CBT referral, 4-week follow-up. Write a complete psychiatric SOAP note with ICD-10 codes.

ChatGPT Output:

S — SUBJECTIVE

CC: “I'm feeling a little better.”

HPI: Patient is a 34-year-old female presenting for follow-up management of Major Depressive Disorder, moderate (F32.1) and Generalized Anxiety Disorder (F41.1). Since last visit 4 weeks ago, patient reports gradual improvement in mood and anxiety symptoms. PHQ-9 today: 12 (prior: 17, ↓5 points — moderate severity, minimal clinically important difference met). GAD-7 today: 9 (prior: 14, ↓5 points — mild-moderate severity). Patient reports sleep improved from approximately 4–5 hrs/night to 6–7 hrs/night since initiation of buspirone. Denies new side effects from sertraline 100mg or buspirone 10mg BID. Appetite adequate. Denies SI/HI. Last PDMP check: [date] — no concerns. Substance use: denies alcohol, tobacco, illicit substances.

O — OBJECTIVE

Vitals: Not obtained (telehealth / outpatient med management — per practice protocol).

MSE: Appearance — well-groomed, appropriately dressed, appears stated age. Behavior — cooperative, good eye contact, no psychomotor agitation or retardation. Speech — normal rate, rhythm, and volume. Mood — “a little better” (patient's words). Affect — mildly constricted, reactive; mood-congruent. Thought Process — linear, logical, goal-directed. Thought Content — no delusions, obsessions, or phobias elicited. Perceptual Disturbances — denies auditory/visual hallucinations. SI/HI — denies suicidal ideation, plan, intent, or means; denies homicidal ideation. Insight — good; patient acknowledges diagnosis and benefit of treatment. Judgment — intact; appropriate social functioning. Cognition — alert and oriented ×4; recent and remote memory grossly intact.

Safety Assessment: Columbia C-SSRS — no ideation, no behavior. Low acute risk.

A — ASSESSMENT

  • F32.1 — Major Depressive Disorder, single episode, moderate: PHQ-9 12, improving trajectory on sertraline 100mg + buspirone augmentation.
  • F41.1 — Generalized Anxiety Disorder: GAD-7 9, significant symptomatic improvement; sleep normalization with buspirone.

Overall clinical trajectory: improving. Treatment response meeting MCID threshold on both rating scales. No safety concerns at this time.

P — PLAN

  1. Continue sertraline 100mg daily — adequate tolerability, partial response at 4 weeks; plan to reassess for full response at week 8.
  2. Continue buspirone 10mg BID — contributing to sleep improvement and anxiety reduction; reassess at 6 weeks.
  3. CBT referral placed today — warm handoff to [therapist name / practice]; evidence-based augmentation for MDD + GAD comorbidity.
  4. Patient education: importance of medication adherence; expected full response timeline 8–12 weeks; avoid abrupt discontinuation.
  5. Safety plan reviewed — patient confirms no SI; emergency contacts updated on file.
  6. Return to clinic in 4 weeks for med management follow-up.

⏱ Time saved: 20 min → 4 min | 80% reduction | 16 min back per patient × 18 patients = 4.8 hours/day

Fully Worked Example 2 — ANCC PMHNP-BC Exam Practice

3 Pharmacology Questions · Time savings: 45 min setup → 8 min (82% reduction)

The Prompt:

Generate 3 ANCC PMHNP-BC style pharmacology practice questions with 4-option multiple choice and full rationale. Topics: (1) first-line antidepressant for MDD with comorbid GAD; (2) lithium toxicity recognition and management; (3) PTSD first-line pharmacotherapy including FDA-approved agents and benzodiazepine contraindication. Include clinical vignette, correct answer with pharmacological rationale, and why each distractor is wrong.

ChatGPT Output:

Question 1 — MDD + Comorbid GAD: First-Line Antidepressant

Vignette: A 28-year-old female presents with a 6-week history of depressed mood, anhedonia, insomnia, and excessive worry about work and relationships. PHQ-9: 14 (moderate MDD). GAD-7: 11 (moderate GAD). No prior psychiatric treatment. No contraindications to antidepressants. Which medication is the best first-line choice?

A. Bupropion 150mg XL daily
B. Sertraline 50mg daily
C. Mirtazapine 15mg nightly
D. Amitriptyline 25mg daily

✓ Correct Answer: B — Sertraline 50mg daily

Rationale: SSRIs (sertraline, escitalopram) and SNRIs (venlafaxine, duloxetine) are FDA-approved for both MDD and GAD, making them the preferred first-line agents when both disorders are present simultaneously. Sertraline has the strongest evidence base for comorbid MDD + GAD and is widely recommended in APA Practice Guidelines.

Why A is wrong: Bupropion is FDA-approved for MDD but lacks FDA approval for GAD and may worsen anxiety due to its dopaminergic/ noradrenergic mechanism — it is explicitly not recommended as monotherapy when GAD is a comorbid diagnosis. This is the highest-yield PMHNP exam trap.

Why C is wrong: Mirtazapine is effective for MDD with insomnia/anxiety but is a second-line agent due to sedation, weight gain, and limited GAD-specific trial data compared to SSRIs/SNRIs.

Why D is wrong: TCAs are third-line due to anticholinergic side effects, cardiac risk, and lethality in overdose — contraindicated as first-line in any patient without prior medication trials.

Question 2 — Lithium Toxicity Recognition and Management

Vignette: A 45-year-old male with Bipolar I Disorder has been stable on lithium carbonate 900mg BID (lithium level 1.0 mEq/L) for 2 years. He presents reporting 3 days of coarse hand tremor, increased urination, and mild nausea. His lithium level today is 1.6 mEq/L. What is the most appropriate next step?

A. Increase fluid intake and recheck lithium level in 1 week
B. Hold lithium and refer to nephrology for evaluation
C. Reduce lithium dose by 50% and recheck level in 3 days
D. Add propranolol for tremor and continue lithium at current dose

✓ Correct Answer: B — Hold lithium and refer to nephrology

Rationale: Lithium has a narrow therapeutic index: therapeutic range 0.8–1.2 mEq/L; levels >1.5 mEq/L are toxic. At 1.6 mEq/L with early toxicity symptoms (coarse tremor, polyuria, nausea), the correct action is to hold lithium immediately and involve nephrology given renal clearance implications. Early signs include coarse tremor (vs. fine intention tremor that is therapeutic), polyuria/polydipsia, nausea/vomiting. Severe signs (>2.0 mEq/L): ataxia, confusion, seizures, cardiac arrhythmia — medical emergency.

Why A is wrong: Waiting a week with a toxic level is dangerous — lithium accumulates with continued dosing; hydration alone is insufficient management.

Why C is wrong: Dose reduction without holding and monitoring is inadequate when the level is already in the toxic range with symptoms.

Why D is wrong: Treating the tremor symptomatically while continuing lithium at a toxic level ignores the underlying toxicity and risks progression to severe toxicity.

Question 3 — PTSD First-Line Pharmacotherapy

Vignette: A 32-year-old female combat veteran presents with a 6-month history of re-experiencing, avoidance, negative cognitions, and hyperarousal following deployment. PCL-5: 48. She reports severe nightmares 4–5 nights/week and insomnia. She has engaged in trauma-focused CBT for 3 months with partial response. Which pharmacotherapy regimen is most appropriate?

A. Lorazepam 0.5mg TID for anxiety and sleep
B. Sertraline 50mg daily + prazosin 1mg nightly for nightmares
C. Quetiapine 25mg nightly for sleep
D. Clonazepam 0.5mg BID for hyperarousal

✓ Correct Answer: B — Sertraline + prazosin for nightmares

Rationale: Sertraline and paroxetine are the ONLY FDA-approved medications for PTSD. Prazosin (alpha-1 antagonist) has robust evidence for PTSD nightmares (VA/DoD Clinical Practice Guideline, multiple RCTs) and is the standard adjunct for nightmare-predominant PTSD. The combination of an SSRI + prazosin addresses both global PTSD symptoms and the nightmare/sleep dimension.

Why A and D are wrong (high-yield exam point): Benzodiazepines are CONTRAINDICATED in PTSD per VA/DoD guidelines, APA guidelines, and the 2023 PTSD treatment consensus. Mechanism: benzodiazepines impair fear extinction learning, worsen PTSD long-term outcomes, increase substance use comorbidity risk, and worsen nightmare/REM sleep architecture. This is one of the most commonly tested PMHNP exam points.

Why C is wrong: Quetiapine is used off-label for PTSD sleep but is not first-line — metabolic risk, sedation, and inferior evidence base compared to sertraline + prazosin for this presentation.

⏱ Time saved: 45 min to build 3 questions manually → 8 min with ChatGPT (82% reduction)

Section A: Clinical Documentation

Six prompts for the core psychiatric documentation that PMHNPs complete every clinic day — psychiatric SOAP notes, safety assessment notes, prior authorization letters for non-formulary antipsychotics, PDMP documentation notes, patient portal medication question replies, and controlled substance agreements. Every prompt generates language aligned with DSM-5-TR diagnostic criteria, ICD-10-CM coding requirements, and CMS documentation standards.

A1

Psychiatric SOAP Note (Med Management Visit)

You are a PMHNP-BC (Psychiatric Mental Health Nurse Practitioner, Board Certified) with 5 years of post-certification outpatient psychiatric practice. Write a complete psychiatric SOAP note for a medication management visit in formal clinical documentation language.

Patient data (de-identified):
- Patient: [age, sex — e.g., 34yo female]
- Visit type: [follow-up / new patient]
- Chief complaint: [in patient's words — e.g., "I'm doing a little better but still anxious"]
- Active diagnoses: [e.g., MDD moderate (F32.1), GAD (F41.1)]
- Current medications: [name, dose, frequency — e.g., sertraline 100mg daily, buspirone 10mg BID]
- Medication changes at last visit: [e.g., added buspirone 10mg BID 3 weeks ago]
- Symptom rating scales: [PHQ-9: X (prior: Y), GAD-7: X (prior: Y), PCL-5 if applicable]
- Medication tolerability: [side effects reported or denied — specify]
- Substance use: [alcohol, cannabis, stimulants — quantity, frequency]
- MSE findings: [appearance, behavior, speech, mood (patient's words), affect, thought process, thought content, SI/HI, insight, judgment, cognition]
- Safety: [SI — ideation/plan/means/intent; HI — ideation/plan/means/intent; access to lethal means]
- Plan changes: [medication adjustments, referrals, labs ordered, follow-up interval]

Write a complete psychiatric SOAP note:
S (Subjective): CC, HPI with symptom trajectory, PHQ-9/GAD-7 scores with change from prior, medication tolerability, substance use
O (Objective): Vitals (if obtained), MSE with all 10 domains (appearance, behavior, speech, mood, affect, thought process, thought content, SI/HI, insight, judgment — add cognition orientation)
A (Assessment): DSM-5-TR diagnostic formulation, ICD-10-CM codes, safety determination
P (Plan): Medication decisions with rationale, referrals, patient education, return visit interval, safety plan if indicated
Formal outpatient psychiatric documentation language. De-identified.
A2

Safety Assessment Note (Suicidal Ideation Evaluation)

Write a complete standalone psychiatric safety assessment note documenting evaluation of suicidal ideation for an outpatient psychiatric patient.

Patient context (de-identified):
- Patient: [age, sex]
- Presenting concern: [e.g., passive SI without plan, reported at check-in on PHQ-9 item 9]
- Risk factors present: [e.g., MDD, prior attempt, social isolation, access to firearms — list all applicable]
- Protective factors present: [e.g., engaged in treatment, children at home, religious beliefs, future orientation — list all]
- SI details: [ideation frequency/intensity/duration; presence of plan; means access; intent to act]
- HI: [yes/no — if yes, target, plan, means]
- Collateral: [family contacted yes/no; information obtained]
- Disposition: [outpatient safety plan, voluntary hospitalization discussed, IVC initiated, emergency contact notified]

Document: risk stratification (low/moderate/high) with clinical rationale, Columbia Suicide Severity Rating Scale (C-SSRS) intensity items, means restriction counseling provided, safety plan review, disposition with rationale. Formal psychiatric documentation language.
A3

Prior Authorization Letter — Non-Formulary Antipsychotic

Write a prior authorization letter to [insurance company name] requesting approval for [medication name, dose, frequency] for a patient with [diagnosis + ICD-10 code].

Clinical context:
- Patient: [age, sex — de-identified]
- Diagnosis: [DSM-5-TR diagnosis + ICD-10 code — e.g., Bipolar I Disorder, current episode manic, F31.10]
- Requested medication: [generic name, brand, dose, frequency, days supply]
- Clinical indication: [why this specific medication is necessary — symptom burden, functional impairment]
- Step therapy completed: [list all formulary alternatives tried, doses used, duration, reason for discontinuation — inadequate response / intolerable side effects / contraindication]
- Contraindications to formulary alternatives: [e.g., metabolic syndrome precluding olanzapine, QTc prolongation precluding quetiapine — specify labs/EKG if applicable]
- Supporting clinical data: [relevant labs, rating scales, hospitalizations, ER visits in the past 12 months]
- Peer-reviewed support: [cite 1–2 guidelines or studies supporting use — e.g., APA Practice Guidelines, CANMAT]

Write a formal prior authorization letter: clinical necessity statement, step therapy documentation, contraindication rationale, supporting evidence, and urgency statement if applicable. Suitable for fax submission.
A4

PDMP Documentation Note

Write a PDMP (Prescription Drug Monitoring Program) review and documentation note for a controlled substance prescribing visit in an outpatient psychiatric practice.

Visit context:
- Patient: [age, sex — de-identified]
- Controlled substance(s) prescribed: [name, DEA schedule, dose, quantity, days supply — e.g., amphetamine salts 20mg BID, Schedule II, #60, 30-day supply]
- PDMP check date/time: [today's date, time]
- PDMP findings: [prescribers identified: X; dispensing pharmacies: X; last fill date: X; any concerns — early fills, multiple prescribers, multiple pharmacies, concerning combinations]
- Aberrant findings: [yes/no — if yes, describe and action taken]
- Urine drug screen: [obtained yes/no; results if available; concordant/discordant]
- Controlled substance agreement: [on file yes/no; reviewed today yes/no]
- Clinical decision: [continue as prescribed / dose adjustment / taper / referral to SUD treatment — with rationale]

Document PDMP review findings, clinical interpretation, any aberrant behavior assessment, and prescribing decision with rationale. Formal psychiatric documentation language compliant with state PDMP requirements.
A5

Patient Portal Medication Question Reply

Write a HIPAA-compliant patient portal message reply from a PMHNP responding to a patient's medication question.

Message context:
- Patient concern: [patient's question — e.g., "I've been on sertraline for 3 weeks and I'm not feeling better yet, should I stop taking it?"]
- Clinical context: [diagnosis, medication, dose, time on medication, any recent changes]
- Key clinical points to address: [e.g., SSRI onset timeline 4–6 weeks, importance of adherence, side effects to monitor, when to call vs. go to ER]
- Any safety screening needed: [if SI/HI concern in message — address directly]
- Next steps: [schedule call, advance appointment, continue current plan]

Write a warm, professional, patient-friendly portal message reply: address the specific question, provide accurate clinical guidance in plain language (6th–8th grade reading level), include appropriate safety language, and state clear next steps. No PHI beyond what is minimally necessary. HIPAA-compliant.
A6

Controlled Substance Agreement

Write a controlled substance (opioid/stimulant/benzodiazepine) treatment agreement for an outpatient psychiatric practice.

Practice context:
- Prescriber: [PMHNP name, credentials, practice name, state]
- Controlled substance class covered: [e.g., Schedule II stimulants (ADHD), Schedule IV benzodiazepines (anxiety), Schedule III/IV buprenorphine (OUD)]
- State-specific requirements: [any state-mandated language — e.g., NC STOP Act provisions for opioids]

Agreement must include:
1. Purpose and risks of controlled substance treatment
2. Patient responsibilities (one prescriber, one pharmacy, no sharing/selling, safekeeping)
3. PDMP monitoring consent and frequency
4. Urine drug screen consent and frequency (random testing policy)
5. Refill policy (no early refills, no lost/stolen prescription replacements after X instances)
6. Conditions for treatment discontinuation (diversion, multiple aberrant UDS, multiple prescribers)
7. Pregnancy and contraception counseling acknowledgment (if applicable — Schedule II stimulants)
8. Patient signature line, date, witness signature line
9. PMHNP co-signature line

Formal, legally clear language appropriate for a North Carolina outpatient psychiatric practice. Plain language where possible.

Section B: Practice Management & Compliance

Six prompts for the administrative and compliance documentation that fills Jordan's afternoons — MIPS quality measures, telehealth CMS compliance, inpatient referral letters, patient-friendly after-visit summaries, HIPAA breach response notes, and the collaborative practice agreement that governs PMHNP scope in restricted-authority states. These prompts ensure every compliance document meets federal and state requirements without spending an hour drafting from scratch.

B1

MIPS Behavioral Health Composite Note

Write a MIPS (Merit-Based Incentive Payment System) quality measure documentation note for an outpatient psychiatric visit. The note must capture all required data elements for the following behavioral health MIPS measures:

Patient/visit context:
- Patient: [age, sex — de-identified]
- Visit diagnoses: [ICD-10 codes — e.g., F32.1 MDD moderate, F41.1 GAD]
- Visit date: [date]
- Eligible measures applicable to this patient/visit:
  - MDD: PHQ-9 score documented and follow-up plan if score ≥5 (MIPS #370 / NQF 0712)
  - Depression remission at 12 months if applicable (MIPS #370)
  - Screening for unhealthy alcohol use (MIPS #173 / NQF 0028) — AUDIT-C score documented
  - Tobacco use screening and cessation counseling (MIPS #226 / NQF 0028)
  - Controlling high blood pressure if hypertension co-diagnosis (MIPS #236)
  - Follow-up after psychiatric hospitalization within 7/30 days if applicable (MIPS #576)

Write structured MIPS documentation addendum: each measure with score/result documented, performance met/not met notation, and any exclusion codes applied. Suitable for EHR quality measure attestation.
B2

Telehealth Psychiatry Note (CMS-Compliant)

Write a complete CMS-compliant telehealth psychiatry visit note for an outpatient medication management encounter conducted via synchronous audio-video.

Visit context:
- Patient: [age, sex — de-identified]
- Visit type: [established patient follow-up / new patient evaluation]
- Telehealth platform: [HIPAA-compliant platform name — e.g., Doxy.me, Epic MyChart Video]
- Visit modality: [synchronous audio-video / audio-only if applicable — specify reason if audio-only]
- Patient location at time of visit: [city, state — required for prescribing across state lines]
- Prescriber location: [city, state]
- State telehealth prescribing compliance: [confirm patient and prescriber states; note any controlled substance telehealth restrictions — Ryan Haight Act considerations for Schedule II–IV]
- Consent obtained: [telehealth consent — verbal/written; document in note]
- Technical issues: [none / specify if connection problems affected visit quality]
- Clinical content: [diagnoses, MSE summary, plan — same as in-person note]

Write a complete telehealth psychiatry note including: modality documentation, CMS Place of Service code (02 for telehealth / 10 for patient home), consent documentation, patient and prescriber location, applicable CPT code (99213/99214/90833 add-on for psychotherapy), and full clinical SOAP content. CMS Telehealth Final Rule 2024 compliant.
B3

Referral Letter to Inpatient Psychiatry

Write a formal referral/transfer letter from an outpatient PMHNP to an inpatient psychiatric facility for a patient requiring a higher level of care.

Clinical context:
- Referring provider: [PMHNP name, credentials, practice name, phone, fax]
- Receiving facility: [hospital name, unit, attending psychiatrist if known]
- Patient: [age, sex, MRN if shared system — de-identified]
- Current diagnoses: [DSM-5-TR + ICD-10 codes]
- Reason for referral: [acute decompensation — describe: SI with plan and means access / acute mania / psychotic break / medication-refractory severe MDD / inability to care for self]
- Current medications: [full list with doses]
- Recent labs: [relevant — lithium level, CBC, CMP, TSH if applicable]
- Hospitalizations in past 12 months: [dates, facilities, discharge diagnoses]
- Outpatient treatment history: [duration of care, medications tried, therapies engaged]
- Safety assessment summary: [C-SSRS score, risk level]
- Disposition: [voluntary admission arranged / IVC initiated / patient en route via EMS]

Write a formal, clinically detailed referral letter suitable for fax transmission to the receiving inpatient facility. Include all elements required for safe handoff and continuity of care.
B4

After-Visit Summary (Plain Language)

Write a patient-friendly after-visit summary for an outpatient psychiatric medication management visit. Plain language, 6th–8th grade reading level.

Visit context:
- Patient name: [first name only — or "you/your"]
- Visit date: [date]
- Provider: [PMHNP name]
- Diagnoses discussed today (plain language): [e.g., depression, anxiety — not just ICD codes]
- Medications — what changed today: [new medications started, doses changed, medications stopped — with plain-language reason for each change]
- Medications — continuing unchanged: [list with plain-language reminder of what each is for]
- Important instructions: [e.g., take sertraline with food if nauseated; avoid alcohol with buspirone; do not stop medications abruptly]
- Side effects to watch for: [specific to medications prescribed — e.g., serotonin syndrome warning signs if applicable]
- When to call the office: [specific symptoms — e.g., new chest pain, severe restlessness, worsening depression]
- When to go to the ER or call 911: [suicidal thoughts with a plan, psychosis, severe medication reaction]
- Crisis resources: [988 Suicide & Crisis Lifeline; local crisis line if applicable]
- Next appointment: [date/time/location/telehealth link]
- Lab work needed before next visit: [if applicable — e.g., lithium level, CBC, metabolic panel]

Write a warm, clear, non-jargon after-visit summary. Format with short paragraphs and bullet points. No medical abbreviations without explanation.
B5

HIPAA Breach Response Note

Write a HIPAA breach response documentation note and patient notification letter for a small outpatient psychiatric practice.

Breach context:
- Practice: [practice name, PMHNP name]
- Date breach discovered: [date]
- Date breach occurred (if known): [date or date range]
- Type of breach: [e.g., unencrypted email containing PHI sent to wrong patient; lost/stolen unencrypted laptop; fax sent to wrong number; ransomware attack; unauthorized workforce member access]
- PHI involved: [type of PHI — name, diagnosis, medication, SSN, DOB — describe without including actual PHI]
- Number of individuals affected: [number]
- Steps taken to contain breach: [immediate actions — e.g., email recalled, device wiped remotely, workforce member access revoked]
- Risk assessment finding: [low probability of PHI compromise / reportable breach — explain determination per 4-factor HHS risk assessment]

Write two documents:
1. Internal breach documentation note (for HIPAA breach log — required 6-year retention): date discovered, date occurred, PHI involved, number affected, risk assessment summary, containment actions, reporting obligations triggered
2. Patient breach notification letter (if reportable): plain language, required HHS elements (what happened, PHI involved, steps taken, what patients can do, contact information), 60-day notification deadline notation
B6

Collaborative Practice Agreement Template (Restricted-Authority States)

Write a collaborative practice agreement (CPA) template for a PMHNP working in a state that requires physician collaboration or supervision.

Practice context:
- PMHNP: [name, credentials, NPI, state license number]
- Collaborating physician: [name, credentials, specialty — psychiatry preferred; internal medicine/family medicine if psychiatrist unavailable, state rules permitting]
- State: [state name — specify any state-specific CPA requirements — e.g., required chart review percentage, geographic proximity rules, required meeting frequency]
- Practice setting: [outpatient psychiatric practice / integrated behavioral health / telehealth]
- Patient population: [adults / adolescents / geriatric — specify]
- Controlled substance prescribing: [included yes/no; schedules covered — state DEA collaborative prescriptive authority requirements]

CPA must include:
1. Parties and credentials
2. Scope of practice — diagnoses PMHNP manages independently
3. Scope of practice — conditions requiring physician consultation
4. Controlled substance prescribing authority (DEA schedules, quantity limits if state-mandated)
5. Chart review requirements (frequency, percentage, documentation method)
6. Emergency consultation protocol
7. Quality improvement and outcome review schedule
8. Liability and malpractice coverage confirmation
9. Agreement duration, renewal terms, termination clause
10. Signatures — PMHNP and physician, date, notarization if state-required

Formal legal-adjacent language appropriate for state board filing. Note: advise attorney review before execution.

Section C: ANCC PMHNP-BC Exam Prep

Six prompts for ANCC PMHNP-BC certification and recertification — from domain-weighted study guides to pharmacology practice questions, psychopathology differentials, psychotherapy modality comparisons, a 40-drug quick-reference table, and a 30-hour CE recertification plan. Jordan uses these to stay sharp on high-yield exam content and to prep new PMHNP graduates in her supervision group.

C1

ANCC PMHNP-BC Domain-Weighted Study Guide

Create a comprehensive ANCC PMHNP-BC exam domain-weighted study guide.

ANCC PMHNP-BC content domains (approximate weights — verify against current ANCC test blueprint):
- Assessment (25%): psychiatric history, MSE, DSM-5-TR diagnostic criteria, rating scales (PHQ-9, GAD-7, C-SSRS, YMRS, PANSS, PCL-5, AUDIT-C, CAGE-AID)
- Psychopharmacology (30%): drug classes, mechanisms, black box warnings, drug-drug interactions, monitoring parameters, therapeutic index drugs
- Psychotherapy (15%): evidence-based modalities (CBT, DBT, ACT, IPT, EMDR), indications, contraindications, theoretical frameworks
- Professional Issues (10%): scope of practice, prescriptive authority by state, mandatory reporting, duty to warn (Tarasoff), involuntary commitment criteria
- Health Promotion / Disease Prevention (10%): metabolic monitoring for antipsychotics, cardiometabolic risk, substance use screening, trauma-informed care
- Special Populations (10%): pediatric/adolescent psychopharmacology, geriatric considerations (Beers Criteria), perinatal psychiatry, LGBTQ+ affirming care

For each domain, provide:
1. High-yield content areas with specific exam trap questions to avoid
2. Top 5 study resources (ANCC-aligned)
3. Recommended study hours allocation
4. 3 sample question stems with answer rationale

Format as a structured 8-week study plan with weekly domain focus and daily hour targets (2–3 hours/day for employed clinicians).
C2

Pharmacology Practice Questions with Rationale (3 Questions)

Generate 3 ANCC PMHNP-BC style pharmacology practice questions with full 4-option multiple choice format and detailed rationale.

Question requirements:
1. First-line antidepressant selection for MDD with comorbid GAD — test knowledge of SSRI/SNRI dual efficacy vs. bupropion limitations in GAD
2. Lithium toxicity recognition and management — therapeutic index 0.8–1.2 mEq/L, early vs. late signs, acute vs. chronic toxicity differences, management steps
3. PTSD first-line pharmacotherapy — FDA-approved agents vs. commonly used non-FDA-approved agents; benzodiazepine contraindication rationale; prazosin for nightmares evidence base

For each question:
- Write a realistic clinical vignette (2–3 sentences) with patient age, sex, diagnosis, relevant history
- 4 options (A–D) with one clearly correct answer and 3 plausible distractors
- Correct answer with full pharmacological rationale (mechanism, evidence, guideline source)
- Explanation of why each distractor is wrong
- High-yield teaching pearl for exam retention

ANCC examination-style language. Evidence-based rationale citing APA Practice Guidelines, FDA labeling, or peer-reviewed literature.
C3

Psychopathology & Differential Diagnosis Questions (3 Questions)

Generate 3 ANCC PMHNP-BC style psychopathology and differential diagnosis practice questions with full rationale.

Topics:
1. Bipolar I vs. Bipolar II vs. Cyclothymia — hypomanic vs. manic episode duration criteria, functional impairment threshold, psychosis specifier
2. Major Depressive Episode vs. Adjustment Disorder with Depressed Mood vs. Persistent Depressive Disorder (Dysthymia) — DSM-5-TR duration criteria, stressor relationship, symptom count
3. Schizophrenia vs. Schizoaffective Disorder vs. Brief Psychotic Disorder — duration criteria, mood episode overlap requirement, functional decline pattern

For each question:
- Realistic clinical vignette with timeline of symptom onset and duration
- 4 options (A–D) — all plausible DSM-5-TR diagnoses
- Correct diagnosis with full DSM-5-TR criterion-by-criterion rationale
- Key differentiating features between all 4 options
- ICD-10-CM code for the correct diagnosis
- Clinical pearl: most common exam trap for this differential

DSM-5-TR criterion language. ANCC examination style.
C4

Psychotherapy Modality Questions — CBT vs. DBT vs. ACT Indications

Generate 3 ANCC PMHNP-BC style psychotherapy modality practice questions — CBT, DBT, and ACT indications, mechanisms, and clinical decision points.

Topics:
1. CBT vs. DBT indications — when to recommend DBT over standard CBT: borderline personality disorder, chronic suicidality, emotional dysregulation, self-harm — DBT modes of treatment (individual, skills group, phone coaching, consultation team)
2. ACT vs. CBT for chronic pain + depression comorbidity — psychological flexibility model vs. cognitive restructuring; when thought defusion is preferable to thought challenging
3. EMDR vs. Prolonged Exposure (PE) vs. CPT for PTSD — trauma processing mechanisms, patient selection (avoidance severity, trauma complexity, dissociation risk), phase structures

For each question:
- Clinical vignette with patient presentation that makes the modality choice non-obvious
- 4 options (A–D): each a different evidence-based modality with a plausible rationale
- Correct answer with mechanism of action, evidence base (RCT / meta-analysis citation), and clinical decision rationale
- Why each incorrect modality is less appropriate for this specific patient
- PMHNP prescribing pearl: medication + therapy combination for this diagnosis (e.g., SSRI + CBT for MDD; DBT + mood stabilizer for BPD)
C5

Top 40 Psychiatric Drug Class Quick-Reference

Create a top 40 psychiatric drug class quick-reference table for ANCC PMHNP-BC exam preparation and daily clinical practice.

Format as a structured table with the following columns for each drug:
| Drug (Generic) | Class/Mechanism | FDA-Approved Indications | Key Monitoring | Black Box Warning | Common Exam Trap |

Drug classes to cover (8 per category — 5 categories):
1. Antidepressants (8): sertraline, escitalopram, venlafaxine, duloxetine, bupropion, mirtazapine, trazodone, phenelzine (MAOI — for drug interactions)
2. Mood Stabilizers & Antiepileptics (8): lithium, valproate, lamotrigine, carbamazepine, oxcarbazepine, gabapentin (off-label only — note), topiramate (off-label — weight), aripiprazole (atypical with mood stabilizer properties)
3. Antipsychotics — First Generation (4): haloperidol, chlorpromazine, fluphenazine, perphenazine — focus on EPS, NMS, TD risk
   Antipsychotics — Second Generation (4): quetiapine, olanzapine, risperidone, clozapine — metabolic monitoring, AIMS
4. Anxiolytics & Hypnotics (8): buspirone, hydroxyzine, lorazepam, clonazepam, diazepam, zolpidem, eszopiclone, suvorexant
5. ADHD & SUD Pharmacotherapy (8): amphetamine salts, methylphenidate, atomoxetine, bupropion (ADHD off-label), naltrexone, acamprosate, disulfiram, buprenorphine/naloxone

Include a "Therapeutic Drug Monitoring" sub-table for drugs with required serum levels: lithium (0.8–1.2 mEq/L therapeutic; >1.5 toxic), valproate (50–125 mcg/mL), carbamazepine (4–12 mcg/mL), clozapine (350–600 ng/mL).
C6

ANCC 30-Hour 2-Year CE Recertification Plan

Create a complete ANCC PMHNP-BC 30-hour 2-year continuing education recertification plan.

ANCC PMHNP-BC recertification requirements (verify against current ANCC requirements):
- 75 CE hours per 5-year recertification cycle (confirm current requirement)
- Pharmacology CE: minimum hours required (confirm ANCC current mandate)
- Specialty hours in psychiatric/mental health nursing
- Practice hours requirement
- ANCC-recognized CE providers

Wait — the ANCC PMHNP-BC recertification cycle is 5 years with 75 CE hours total. Please generate a plan for:
- 30 hours of CE per 2-year period (covering the first two years of a 5-year cycle)
- Pharmacology requirement met within the 30 hours
- Sources: ANCC-accredited providers (APNA, ANA, AANP, Relias, Medscape CE, PCNE)
- Mix of: live conferences (APNA Annual Conference), online self-study, simulation, journal CE

Provide:
1. 30-hour distribution table: CE category, topic, provider, format (online/live), estimated hours, cost range, ANCC credit type
2. Pharmacology hours tracker (highlight which courses fulfill pharmacology requirement)
3. Month-by-month completion calendar (spread over 24 months — avoid last-minute cramming)
4. Free vs. paid CE sources with links or search terms
5. Documentation tips: how to track CE in ANCC's certification renewal portal

Section D: Administrative

Four prompts for the high-stakes administrative documentation that rarely has templates in the EHR — involuntary hold documentation, adverse event incident reports, annual self-evaluations, and scope-of-practice clarification memos. These prompts handle the situations where a wrong word creates liability, so the language has to be precise.

D1

Involuntary Hold Documentation (5150/5585 or State Equivalent)

Write a complete involuntary psychiatric hold documentation note for an outpatient PMHNP initiating an involuntary commitment evaluation.

Clinical context:
- State: [state — note: "5150" is California WIC; other states use different statutes — e.g., NC: Involuntary Commitment (IVC) Petition under G.S. 122C; specify your state]
- Patient: [age, sex — de-identified]
- Basis for hold: [danger to self / danger to others / grave disability — specify which criterion(ia) met]
- Clinical findings supporting hold:
  - SI/HI: [ideation, plan, means, intent — document specifically]
  - Recent behavior: [self-harm attempt, threatening statements, inability to care for self — specify]
  - MSE: [relevant findings — thought content, insight, judgment]
  - Protective factors assessed and insufficient: [list]
  - Voluntary treatment offered and refused or patient unable to engage: [document]
- Less restrictive alternatives considered and ruled out: [outpatient safety plan, crisis respite, intensive outpatient — why insufficient]
- Disposition: [EMS called / law enforcement notified / patient transported to ED / petition filed with magistrate — specify state process]
- Collateral contacted: [family/emergency contact — what was communicated]

Write a legally defensible involuntary hold documentation note citing the applicable state statute, all three-part criteria assessed, clinical findings for each criterion, less-restrictive alternatives considered, and disposition. Formal clinical-legal language.
D2

Adverse Event Incident Report

Write a formal adverse event incident report for an outpatient psychiatric practice.

Incident context:
- Practice: [practice name]
- Date/time of incident: [date, time]
- Patient: [de-identified — age, sex, MRN or case number]
- Type of adverse event: [e.g., patient suicide attempt between appointments; medication error — wrong dose transmitted to pharmacy; patient elopement from waiting room before safety assessment completed; medication adverse reaction — serotonin syndrome; breach of confidentiality — clinical information shared with unauthorized family member]
- Description of incident: [factual, chronological account — what happened, when, who was involved, what was discovered and when]
- Immediate actions taken: [EMS called / patient contacted / pharmacy notified / patient returned for evaluation — specify]
- Patient outcome: [current status if known]
- Witnesses: [staff present — names/roles, no patient identifiers]
- Root cause (preliminary): [systemic factors — workflow gap, communication failure, documentation error, patient factor]
- Corrective actions initiated: [immediate / short-term / long-term — specify]
- Reporting obligations triggered: [state licensing board / malpractice carrier / health department / HIPAA breach — specify which apply]

Write a formal incident report: objective, factual, no speculation about liability. Complete all standard fields. Suitable for practice quality file and malpractice carrier notification.
D3

Annual Self-Evaluation with SMART Goals

Write a comprehensive annual self-evaluation for a PMHNP-BC in outpatient psychiatric practice, structured around SMART goals and ANCC certification competencies.

Practice context:
- Review period: [start date – end date]
- Practice setting: [outpatient psychiatric practice, solo/group, patient population]
- Panel: [number of active patients, diagnoses managed]
- Productivity: [patients/day, total encounters/year, no-show rate]
- Quality metrics: [PHQ-9 remission rate if tracked, 30-day readmission rate, patient satisfaction scores if available]
- CE completed this year: [hours, topics]
- Professional development: [conferences attended, publications, supervision provided, committees]
- Challenges encountered: [documentation burden, prior auth volume, complex patients, staff issues]

Self-evaluation structure:
1. Clinical Practice Competencies (with SMART goals for next year): assessment accuracy, pharmacotherapy outcomes, safety assessment, documentation quality
2. Professional Practice Competencies: CE completion, certification maintenance, peer consultation, supervision
3. Quality Improvement: a specific QI project proposed or completed (PHQ-9 tracking, medication reconciliation, no-show reduction)
4. Leadership/Collaboration: interdisciplinary communication, referral relationships, community mental health engagement
5. Career Development Goal: one 12-month career goal (DNP enrollment, private practice launch, supervision certification, publication)

SMART format for each goal: Specific, Measurable, Achievable, Relevant, Time-bound — with baseline metric and target metric.
D4

Scope-of-Practice Memo — PMHNP vs. Psychiatrist

Write a professional scope-of-practice clarification memo for a PMHNP in full practice authority state (North Carolina), clarifying the PMHNP's independent practice scope relative to psychiatrists and other psychiatric providers.

Purpose: [e.g., for new referral partners / primary care collaborators / insurance credentialing / new patient education / onboarding new front desk staff]

Memo must address:
1. PMHNP credentials and licensure: MSN + ANCC PMHNP-BC certification + NC APRN license + DEA registration (Schedules II–IV)
2. North Carolina full practice authority: NC Session Law 2023 APRN Modernization Act — no physician collaboration or supervision requirement (confirm current NC law status)
3. What PMHNPs do independently in NC: psychiatric evaluation and diagnosis (DSM-5-TR), psychopharmacology management including controlled substances (Schedule II–IV), psychotherapy delivery, inpatient/outpatient/telehealth practice
4. How PMHNP practice compares to psychiatrist (MD/DO): educational pathway differences, prescribing authority overlap in full-practice-authority states, when psychiatric consultation or co-management is appropriate (ECT, TMS, complex forensic evaluations, inpatient attending of record at some facilities)
5. What PMHNPs do NOT do independently (regardless of state): perform ECT (electroconvulsive therapy), serve as inpatient attending of record at facilities that require MD/DO, sign death certificates, perform surgical procedures
6. Insurance and credentialing: PMHNPs credential and bill independently under NPI in full-practice-authority states; Medicare/Medicaid enrollment as non-physician practitioner

Professional, factual tone. Suitable for sharing with primary care offices, insurance panels, and new patients.

Section E: Career Development

Four prompts for career advancement — from job applications and LinkedIn positioning to DNP program essays and salary negotiations. Whether Jordan is exploring private practice, a health system role, or the DNP pathway, these prompts produce polished, credentialed-professional-level career documents in minutes.

E1

Cover Letter — Employed Health System + Private Practice Versions

Write two cover letters for a PMHNP-BC with 5 years of post-certification outpatient psychiatric experience.

PMHNP profile:
- Name: [name]
- Credentials: MSN, PMHNP-BC, ANCC certified
- State: North Carolina (full practice authority)
- Experience: 5 years post-certification, outpatient psychiatric practice, 120-patient panel
- Specialties: MDD, GAD, ADHD, bipolar I/II, PTSD, schizoaffective disorder
- Controlled substance prescribing: Schedule II–IV (stimulants, benzodiazepines, buprenorphine)
- Telehealth experience: [yes/no, platform]
- Supervision: [supervised PMHNP students yes/no]

Version 1 — Health System / FQHC / Hospital Employed Role:
- Target: behavioral health integration director role at a multi-site FQHC OR inpatient consult-liaison PMHNP position
- Emphasis: collaborative care model experience, high-volume practice, EHR proficiency, quality metrics, team-based care

Version 2 — Private Practice / Group Practice Partnership:
- Target: joining an established group practice as a partner-track PMHNP or launching an independent private practice
- Emphasis: full practice authority, independent prescribing including Schedule II, business acumen, patient panel management, telehealth capacity

Each cover letter: 3 paragraphs, under 350 words, specific accomplishments with metrics where possible, professional but warm tone, strong closing with salary range approach.
E2

LinkedIn Headline + Summary — 3 Career Tracks

Write LinkedIn headlines and About section summaries for a PMHNP-BC across three career positioning tracks.

PMHNP profile:
- Credentials: MSN, PMHNP-BC
- State: North Carolina (full practice authority)
- Experience: 5 years post-ANCC certification, outpatient psychiatric practice
- Clinical focus: complex psychiatric medication management (MDD, bipolar, PTSD, ADHD, schizoaffective), controlled substance prescribing
- Additional: telehealth psychiatry experience, PMHNP student supervision

Track 1 — Clinical Expert / Direct Care:
- Headline: (under 220 characters, keyword-optimized for PMHNP recruiter searches)
- About: (300–500 words) — clinical credibility, patient outcomes focus, complex case management, full practice authority differentiation

Track 2 — Telehealth / Direct Primary Care / Virtual Psychiatry:
- Headline: telehealth-specific positioning, platforms, async care
- About: technology-forward psychiatric care, access expansion, solo practice / group telehealth model

Track 3 — Education / Faculty / Clinical Supervision:
- Headline: PMHNP preceptor, academic psychiatry, DNP bridge
- About: teaching philosophy, supervision methodology, academic credentials, research or QI interest

For each track: include 5 keyword-rich skills to add to the Skills section, and 2 featured post ideas relevant to PMHNP professionals on LinkedIn.
E3

DNP Personal Statement

Write a post-master's Doctor of Nursing Practice (DNP) personal statement for a PMHNP-BC applying to a DNP completion program.

Applicant context:
- Current credentials: MSN, PMHNP-BC, 5 years post-certification clinical experience
- Target program: [program name — post-master's DNP, psychiatric/mental health NP track or executive leadership track]
- Clinical QI focus: [proposed DNP capstone project area — e.g., PHQ-9 screening integration in outpatient psychiatry, medication adherence in serious mental illness, telehealth access expansion for rural MH, PDMP-integrated ADHD stimulant prescribing protocol]
- PICO or practice problem statement: [frame the clinical problem your capstone will address]
- Career goal post-DNP: [e.g., PMHNP faculty, practice owner, health system behavioral health director, policy advocacy]

Personal statement structure (750–1,000 words):
1. Opening hook — a specific patient encounter (de-identified) that revealed a systemic gap in psychiatric care
2. Clinical journey — MSN to PMHNP-BC, practice growth, what 5 years taught you about practice gaps
3. The gap — state the specific practice problem your capstone will address, with population data (prevalence, cost, outcome disparities)
4. Your preparation — relevant clinical experience, QI exposure, any leadership or teaching
5. Why this program — specific faculty, research alignment, clinical practicum sites
6. Post-DNP vision — how the degree advances your practice, your patients, and psychiatric nursing

Authentic, specific, non-generic. No AI boilerplate ("I have always been passionate about..."). Formal academic tone with a clinical voice.
E4

Salary Negotiation Talking Points

Write salary negotiation talking points for a PMHNP-BC with 5 years of post-certification experience negotiating a new position.

Negotiation context:
- Current role: outpatient psychiatric practice, full-time, employed
- Target role: [e.g., health system employed PMHNP / group practice partnership / FQHC / telehealth company]
- State: North Carolina (full practice authority — no collaborating physician overhead cost to employer)
- Offer received (if applicable): [$XXX,XXX base + benefits — describe]
- Market data sources to reference: AANP Annual Salary Survey, APNA salary benchmarks, Bureau of Labor Statistics OES for NPs, Medscape NP Compensation Report

Talking points to develop:
1. Market rate anchor — AANP/APNA benchmark for PMHNP in NC (full practice authority premium), years of experience multiplier, specialty premium (psychiatric controlled substance prescribing)
2. Full practice authority value proposition — no physician supervision cost, independent billing, DEA Schedule II–IV prescribing = higher RVU generation
3. Panel productivity — 120-patient panel, 18 patients/day, documented with metrics
4. Controlled substance prescribing premium — Adderall/Suboxone/buprenorphine panel management = higher reimbursement per visit
5. Non-salary negotiables — sign-on bonus, student loan repayment, CE/conference budget ($3,000+/year), DEA renewal reimbursement, malpractice tail coverage, schedule flexibility, telehealth day
6. Counter-offer script — specific language for when the employer says "this is our standard offer"
7. Walk-away number — how to determine your BATNA and communicate it professionally

Professional, confident, evidence-based negotiation language. Include specific dollar ranges where AANP data supports them.

Daily Time Savings for Jordan: The Math

TaskBefore ChatGPTWith ChatGPTSaved / visit
Psychiatric SOAP note20 min4 min16 min
Prior auth letter25 min5 min20 min
PDMP documentation note8 min2 min6 min
Patient portal reply10 min2 min8 min
After-visit summary10 min2 min8 min

18 patients × 16 min saved on SOAP notes alone = 4.8 hours returned every clinic day.

Add prior auths, PDMP notes, and portal replies and the total daily savings exceeds 5 hours — enough to see 4–5 additional patients, leave the office by 5 PM, or finally finish that CE module before the recertification deadline.

Get Every PMHNP Prompt in the AI Prompt Bible

The 26 prompts above are just the PMHNP chapter. The AI Prompt Bible covers 150+ healthcare and professional credential clusters — psychiatric SOAP notes, ANCC exam prep, controlled substance agreements, telehealth compliance notes, and every administrative task a working PMHNP-BC faces, all in one searchable, copy-paste reference.

Get the AI Prompt Bible →

Keywords: ChatGPT for psychiatric mental health nurse practitioners, AI prompts for PMHNP, PMHNP documentation ChatGPT, PMHNP board exam prep ChatGPT, ANCC PMHNP-BC exam prep AI, psychiatric SOAP note ChatGPT, PMHNP prior authorization letter AI